（2020年7月30日，/HRoot.com/）近日，据瀚纳仕的最新研究显示，在疫情期间，新加坡的生命科学领域人才需求稳定。
研究发现，尽管很多组织在此时可能不会扩大团队规模，但他们仍保持着现有的团队优势，从而保持对替代招聘的稳定需求。作为创新和研发中心，当前新加坡市场和企业的新入局者也有招聘需求，希望扩大其在亚洲的业务和声誉。
分析发现，新冠疫情危机迫使许多组织在最短时间内无法适应环境，从而使一些组织难以在当前的竞争格局中找到立足之地。这导致更多公司将重点转移到有助于应对疫情的产品，服务、设施和分销渠道。由于缺乏寻求销售人员的渠道和需求，生命科学中的商业销售职能受到新冠疫情影响*大的部门之一。
瀚纳仕表示，由于许多企业将重点转向新冠疫情相关产品和服务，加上供应链和物流的严重中断，使新加坡的许多生命科学组织在持续的经济不确定性中处于劣势。尽管如此，该行业的前景仍然乐观，资金充足，有更多的大公司和投资者进入当地市场，以利用城市提供的准入机会、稳定和商业支持。
瀚纳仕补充表示，随着越来越多的企业恢复其年度招聘和扩张计划，就业市场正在呈现中期复苏。生命科学投资公司也继续在新加坡扩大范围。
尽管就业机会增加，但生命科学候选市场仍然“人才短缺”。市场上越来越多的裁员也导致涌入了一批“不一定合适的候选人”。瀚纳仕表示，人力资源或人才培养团队需要更多时间来筛选潜在候选人。这种趋势已导致更多组织探索与外部机构合作，以在这个充满挑战的市场中进行招聘。
瀚纳仕新加坡区域总监Grant Torrens表示：“虽然生命科学领域肯定会面临挑战，但新加坡稳定的经济和监管环境是未来光明前景的有力指标。”
Torrens表示：“考虑到当前疫情导致的不稳定以及该行业的人才紧缩，瀚纳仕建议希望招聘顶尖人才的组织扩大招聘标准，以充分利用当前的候选人市场。他们还可以通过专注于改善雇主品牌，提供低成本、高价值的福利（如灵活和远程工作），着重于生产力（而不是工时）并促进工作与生活的平衡，来增强其人才吸引战略。”
SINGAPORE – LIFE SCIENCES SECTOR SEES STEADY DEMAND DESPITE CHALLENGES: HAYS
(Jul.30, 2020, /staffingindustry.com/)Singapore’s life sciences sector found steady demand amid the pandemic, according to new research from Hays.
The research found that while organisations may not be expanding their teams at this time, they are still holding up their current team strengths, leading to a steady demand for replacement hiring. There has also been hiring demand from new entrants in the market and businesses looking to expand their Asian presence owing to Singapore’s reputation of being a hub for innovation and research and development
The analysis found that the Covid-19 crisis has forced many organisations to adjust to disruptions within the shortest time available, causing some to struggle to find their footing in the present competitive landscape. This has led to more companies shifting their focus towards products, services, facilities and distribution channels that can aid in the pandemic response. Commercial sales functions within the life sciences have been amongst the most impacted by the pandemic, owing to the lack of access and demand for salespeople.
The shift of focus to Covid-19 related products and services coupled with significant disruptions to supply chain and logistics has put many life sciences organisations in Singapore on the backfoot amidst ongoing economic uncertainty, according to Hays. But despite this, the outlook for the sector remains buoyant and well financed, with more big players and investors making their entrance into the local market to capitalise on the access, stability and business support the city offers.
Hays added that the job market is showing a mid-year recovery as more businesses get back on track with their annual hiring and expansion plans. Life science investment companies also continue to set up shop in Singapore.
Despite increasing opportunities, the life sciences candidate market remains ‘talent short’. The increasing number of redundancies in the market has also led to an influx of candidates who “may not necessarily be the right fit.” Hays adds that more time required for HR or talent acquisition teams to shortlist a potential candidate. This trend has led to more organisations exploring working with external agencies to hire in this challenging market.
Grant Torrens, Regional Director of Hays Singapore said, “While the life sciences sector is certainly seeing its share of challenges, Singapore’s stable economy and regulatory environment are strong indicators of a bright future ahead.”
“Taking into consideration the ongoing pandemic-led instability as well as talent crunch in the sector, organisations looking to hire top talent are advised to broaden their hiring criteria to take full advantage of the current candidate market. They can also strengthen their talent attraction strategies by focusing their energies on improving their employer branding and offering low-cost yet high-value benefits like flexible and remote working, focusing on productivity (rather than hours) and promoting work-life balance,” Torrens said.